These findings indicate that activation of the BDNF–TrkB–CREB pathway by trazodone may extend downstream to enhance hippocampal neurogenesis, which is critically impaired in Alzheimer’s disease. The gene discussed is NTRK2; the disease is early-onset autosomal dominant Alzheimer disease.